Adverum Biotechnologies Stock Forward View

ADVMDelisted Stock  USD 4.36  0.00  0.00%   
Adverum Stock outlook is based on your current time horizon.
As of now, the value of RSI of Adverum Biotechnologies' share price is approaching 46. This suggests that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Adverum Biotechnologies, making its price go up or down.

Momentum 46

 Impartial

 
Oversold
 
Overbought
The successful prediction of Adverum Biotechnologies' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Adverum Biotechnologies and does not consider all of the tangible or intangible factors available from Adverum Biotechnologies' fundamental data. We analyze noise-free headlines and recent hype associated with Adverum Biotechnologies, which may create opportunities for some arbitrage if properly timed.
Using Adverum Biotechnologies hype-based prediction, you can estimate the value of Adverum Biotechnologies from the perspective of Adverum Biotechnologies response to recently generated media hype and the effects of current headlines on its competitors.
The Naive Prediction forecasted value of Adverum Biotechnologies on the next trading day is expected to be 4.41 with a mean absolute deviation of 0.14 and the sum of the absolute errors of 8.29.

Adverum Biotechnologies after-hype prediction price

    
  USD 4.36  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.

Adverum Biotechnologies Additional Predictive Modules

Most predictive techniques to examine Adverum price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Adverum using various technical indicators. When you analyze Adverum charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
A naive forecasting model for Adverum Biotechnologies is a special case of the moving average forecasting where the number of periods used for smoothing is one. Therefore, the forecast of Adverum Biotechnologies value for a given trading day is simply the observed value for the previous period. Due to the simplistic nature of the naive forecasting model, it can only be used to forecast up to one period.

Adverum Biotechnologies Naive Prediction Price Forecast For the 20th of February

Given 90 days horizon, the Naive Prediction forecasted value of Adverum Biotechnologies on the next trading day is expected to be 4.41 with a mean absolute deviation of 0.14, mean absolute percentage error of 0.04, and the sum of the absolute errors of 8.29.
Please note that although there have been many attempts to predict Adverum Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Adverum Biotechnologies' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Adverum Biotechnologies Stock Forecast Pattern

Backtest Adverum Biotechnologies  Adverum Biotechnologies Price Prediction  Research Analysis  

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Adverum Biotechnologies stock data series using in forecasting. Note that when a statistical model is used to represent Adverum Biotechnologies stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria114.9028
BiasArithmetic mean of the errors None
MADMean absolute deviation0.1359
MAPEMean absolute percentage error0.0323
SAESum of the absolute errors8.2887
This model is not at all useful as a medium-long range forecasting tool of Adverum Biotechnologies. This model is simplistic and is included partly for completeness and partly because of its simplicity. It is unlikely that you'll want to use this model directly to predict Adverum Biotechnologies. Instead, consider using either the moving average model or the more general weighted moving average model with a higher (i.e., greater than 1) number of periods, and possibly a different set of weights.

Predictive Modules for Adverum Biotechnologies

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Adverum Biotechnologies. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Adverum Biotechnologies' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
3.164.365.56
Details
Intrinsic
Valuation
LowRealHigh
2.413.614.81
Details

Adverum Biotechnologies After-Hype Price Density Analysis

As far as predicting the price of Adverum Biotechnologies at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Adverum Biotechnologies or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Adverum Biotechnologies, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Adverum Biotechnologies Estimiated After-Hype Price Volatility

In the context of predicting Adverum Biotechnologies' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Adverum Biotechnologies' historical news coverage. Adverum Biotechnologies' after-hype downside and upside margins for the prediction period are 3.16 and 5.56, respectively. We have considered Adverum Biotechnologies' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
4.36
4.36
After-hype Price
5.56
Upside
Adverum Biotechnologies is somewhat reliable at this time. Analysis and calculation of next after-hype price of Adverum Biotechnologies is based on 3 months time horizon.

Adverum Biotechnologies Stock Price Outlook Analysis

Have you ever been surprised when a price of a Company such as Adverum Biotechnologies is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Adverum Biotechnologies backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Adverum Biotechnologies, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.41 
1.20
 0.00  
  0.05 
8 Events / Month
8 Events / Month
In about 8 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
4.36
4.36
0.00 
0.00  
Notes

Adverum Biotechnologies Hype Timeline

Adverum Biotechnologies is presently traded for 4.36. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -0.05. Adverum is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is presently at 0.41%. %. The volatility of related hype on Adverum Biotechnologies is about 1043.48%, with the expected price after the next announcement by competition of 4.31. About 13.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.93. Some equities with similar Price to Book (P/B) outperform the market in the long run. Adverum Biotechnologies recorded a loss per share of 8.57. The entity had not issued any dividends in recent years. The firm had 1:10 split on the 21st of March 2024. Given the investment horizon of 90 days the next anticipated press release will be in about 8 days.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.

Adverum Biotechnologies Related Hype Analysis

Having access to credible news sources related to Adverum Biotechnologies' direct competition is more important than ever and may enhance your ability to predict Adverum Biotechnologies' future price movements. Getting to know how Adverum Biotechnologies' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Adverum Biotechnologies may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
ARTVArtiva Biotherapeutics Common 0.10 4 per month 7.49  0.05  7.64 (11.11) 118.69 
GUTSFractyl Health Common(0.02)10 per month 0.00 (0.07) 11.89 (8.44) 85.71 
STROSutro Biopharma(0.99)7 per month 4.75  0.21  11.87 (7.78) 29.10 
DTILPrecision BioSciences(0.25)9 per month 0.00 (0.16) 5.99 (7.57) 15.28 
MGXMetagenomi Common Stock(0.03)10 per month 0.00 (0.09) 6.21 (5.29) 18.63 
ALXOAlx Oncology Holdings(0.12)9 per month 5.29  0.16  13.04 (9.02) 23.85 
ATYRaTyr Pharma(0.04)9 per month 3.56  0.10  10.23 (6.41) 35.20 
BMEABiomea Fusion(0.13)7 per month 5.40  0.0001  9.38 (8.33) 28.51 
PLRXPliant Therapeutics 0.01 7 per month 0.00 (0.15) 4.59 (6.82) 18.94 
QNCXQuince Therapeutics 0.32 9 per month 18.83  0.06  16.82 (16.67) 369.99 

Adverum Biotechnologies Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Adverum Biotechnologies stock to make a market-neutral strategy. Peer analysis of Adverum Biotechnologies could also be used in its relative valuation, which is a method of valuing Adverum Biotechnologies by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Adverum Biotechnologies Market Strength Events

Market strength indicators help investors to evaluate how Adverum Biotechnologies stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Adverum Biotechnologies shares will generate the highest return on investment. By undertsting and applying Adverum Biotechnologies stock market strength indicators, traders can identify Adverum Biotechnologies entry and exit signals to maximize returns.

Adverum Biotechnologies Risk Indicators

The analysis of Adverum Biotechnologies' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Adverum Biotechnologies' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting adverum stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Story Coverage note for Adverum Biotechnologies

The number of cover stories for Adverum Biotechnologies depends on current market conditions and Adverum Biotechnologies' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Adverum Biotechnologies is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Adverum Biotechnologies' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Adverum Biotechnologies Short Properties

Adverum Biotechnologies' future price predictability will typically decrease when Adverum Biotechnologies' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Adverum Biotechnologies often depends not only on the future outlook of the potential Adverum Biotechnologies' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Adverum Biotechnologies' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding19.8 M
Cash And Short Term Investments125.7 M
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.
You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Other Consideration for investing in Adverum Stock

If you are still planning to invest in Adverum Biotechnologies check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Adverum Biotechnologies' history and understand the potential risks before investing.
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Global Correlations
Find global opportunities by holding instruments from different markets
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital